Foxg1 Research Foundation

This is the first human study testing FRF-001, a gene therapy delivered directly to the brain, for people with FOXG1 syndrome. The trial will enroll 12 children and adults to check if the treatment is safe and if it helps improve movement skills. Researchers will inject the thera…